Apr 2024

Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT

Burger PM, Bhatt DL, Dorresteijn JAN, et al.

First published: April 27, 2024  DOI: 10.1093/ehjcvp/pvae030